Deutetrabenazine Associated With Long-Term Improvements for Tardive Dyskinesia - Psychiatry Advisor

Psychiatry AdvisorDeutetrabenazine Associated With Long-Term Improvements for Tardive DyskinesiaPsychiatry AdvisorNEW YORK – Deutetrabenazine (DTB) is associated with long-term improvements in abnormal movements for patients with tardive dyskinesia, per the results of a study presented at the 2018 American Psychiatric Association (APA) Annual Meeting, held May 5 ...